Sudeep Pharma Ltd

Sudeep Pharma Other Announcement

Sudeep Pharma cancelled its analyst/investor plant visit scheduled for 23–24 September 2026 due to exigencies. No financial or operational impact is indicated.

Sudeep Pharma Other Announcement

Sudeep Pharma Limited corrected a clerical error regarding the number of attendees at its Annual General Meeting, updating the count from 45 to 44.

Sudeep Pharma Investor Presentation: Key Takeaways

Sudeep Pharma reported strong Q1FY27 performance with 27% YoY revenue growth. Strategy focuses on expanding into Specialty Ingredients and high-growth Battery Materials (SAM project).

Sudeep Pharma Q1 FY27 Results: Net Profit ₹40.6 Cr, Up 29.7% YoY

Sudeep Pharma Ltd reported revenue from operations of ₹158.3 Cr (+26.7% YoY) and net profit of ₹40.6 Cr (+29.7% YoY) for Q1 FY27.

Key figure

Net profit ₹40.6 Cr · +29.7% YoY

Sudeep Pharma Annual General Meeting

Sudeep Pharma Limited held its 37th Annual General Meeting on August 4, 2026. The meeting transacted business including financial statement approval, director appointments, dividend declaration, and ESOP schemes.

Sudeep Pharma Capital Structure Change

Nuvama Crossover Opportunities Funds reduced their stake in Sudeep Pharma Ltd. The promoter field is 'No', indicating a non-promoter equity transaction.

Sudeep Pharma Earnings Call Transcript: Key Takeaways

Sudeep Pharma reported strong H1 FY26 growth, despite Q2 US tariff headwinds causing temporary revenue slippage. The transition towards high-margin specialty ingredients and battery materials via the 'Sam' vertical defines their strategic pivot.

Sudeep Pharma Board Meeting Date

Sudeep Pharma has scheduled a Board meeting for August 4, 2026, to consider and approve the unaudited standalone and consolidated financial results for the June quarter.

Sudeep Pharma Dividend

Sudeep Pharma Ltd announced a final dividend of ₹1.50 per share. The record date is set for 23 July 2026.

Sudeep Pharma Annual General Meeting

Sudeep Pharma Ltd will hold its 37th AGM on 4 Aug 2026 via video conference. The agenda includes dividend of Rs.1.50 per share and director re‑appointment.

Sudeep Pharma Annual Report

Sudeep Pharma filed its FY 2025-26 Annual Report with BSE, declaring a ₹1.50 final dividend. It reports a market cap of ₹6,693 crore and entry into battery materials.